<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Liquidia Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Liquidia Technologies, Inc.

    Liquidia is a late-stage clinical biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary PRINT technology to transform the lives of patients. Currently, Liquidia is focused on the development of two product candidates using its PRINTÂŽ particle engineering platform: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $166,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Neal Fowler
    • FOUNDED
      2004
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Exact Sciences Corporation

    Exact Sciences Corporation

    Exact Sciences Corp. (NASDAQ: EXAS) is committed to playing a role in the eradicat...

    Exact Sciences Corp. (NASDAQ: EXAS) is committe...

    Filing Type:    PU
    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a clinical-stage biopharmaceutical c...

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a...

    Filing Type:    PU
    Innoviva, Inc.

    Innoviva, Inc.

    Innoviva, Inc. (NASDAQ: INVA) is focused on royalty management. Innoviva’s portf...

    Innoviva, Inc. (NASDAQ: INVA) is focused on roy...

    Filing Type:    PU
    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Anavex utilizes precision genetic medicine to treat severe and devastating neurolo...

    Anavex utilizes precision genetic medicine to t...

    Filing Type:    PU
    Akorn, Inc.

    Akorn, Inc.

    Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and mark...

    Akorn, Inc. is a niche pharmaceutical company t...

    Filing Type:    PU
    Dova Pharmaceuticals, Inc.

    Dova Pharmaceuticals, Inc.

    Dova is a pharmaceutical company focused on acquiring, developing and commercializ...

    Dova is a pharmaceutical company focused on acq...

    Filing Type:    PU
    Daiichi Sankyo Co., Ltd.

    Daiichi Sankyo Co., Ltd.

    Founded on September 28, 2005 through the merger of Daiichi Pharmaceutical and San...

    Founded on September 28, 2005 through the merge...

    Filing Type:    PU
    Kitov Pharma Ltd.

    Kitov Pharma Ltd.

    Kitov Pharma is an innovative biopharmaceutical drug development company. Leveragi...

    Kitov Pharma is an innovative biopharmaceutical...

    Filing Type:    PU
    Morphic Holding, Inc.

    Morphic Holding, Inc.

    Morphic Therapeutic is leading the development of a new generation of oral integri...

    Morphic Therapeutic is leading the development ...

    Filing Type:    PU
    JanOne Inc.

    JanOne Inc.

    JanOne, formerly Appliance Recycling Centers of America, Inc., and subsidiaries, i...

    JanOne, formerly Appliance Recycling Centers of...

    Filing Type:    PU
    Insitu Biologics, Inc

    Insitu Biologics, Inc

    InSitu Biologics is an emerging biotech company focusing on development of AnestaG...

    InSitu Biologics is an emerging biotech company...

    Amount Raised:    $2,000,000.00
    Fundraising Status:    EC
    Filing Type:    RA
    Nektar Therapeutics

    Nektar Therapeutics

    Nektar Therapeutics is a research-based development stage biopharmaceutical compan...

    Nektar Therapeutics is a research-based develop...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.